The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women
- PMID: 21146673
- PMCID: PMC3058560
- DOI: 10.1016/j.ahj.2010.08.002
The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women
Abstract
Background: Variation in the Fat-Mass and Obesity-Associated (FTO) gene has been associated with obesity, diabetes, and hypertension. However, its association with cardiovascular disease (CVD) in healthy populations and any interaction with physical activity remain unclear.
Methods: The FTO rs8050136 allele was determined in a prospective cohort study of 21,674 apparently healthy White US women in the Women's Genome Health Study.
Results: During a mean follow-up of 12.7±2.0 years, 664 incident CVD events occurred. The risk allele (A) was associated with higher prevalence of hypertension, diabetes, and metabolic syndrome (all P<.05). In a multivariate model, there was significant association of the risk allele with CVD (hazard ratio [HR] per allele copy 1.14, 95% CI 1.01-1.28) that was no longer significant after additional adjustment for body mass index (BMI) (HR 1.10, 95% CI 0.97-1.23). There was statistical evidence of an interaction between FTO and physical activity (P=.048). We found a significant association of FTO with CVD only among less-active (≤8.8 metabolic equivalent-h/wk) women (HR 1.19, 95% CI 1.02-1.38) in multivariate analyses that included BMI. More-active women did not have this increased risk (HR 0.96, 95% CI 0.79-1.16]). In a model that adjusted for BMI, less-active/high-risk (A/A) women were at 54% increased risk of developing CVD (HR 1.54, 95% CI 1.13-2.11), compared to more-active/low-risk (C/C) women.
Conclusions: Carriers of the FTO risk allele have an increased risk of CVD mediated by BMI. There appears to be an interaction with physical activity, such that this risk increase is only in less-active women.
Copyright © 2010 Mosby, Inc. All rights reserved.
Conflict of interest statement
Dr. Lee serves as a consultant to Virgin HealthMiles, and sits on its Scientific Advisory Board.
References
-
- James WP. WHO recognition of the global obesity epidemic. Int J Obes (Lond) 2008;32 (Suppl 7):S120–6. - PubMed
-
- Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008;9:246–50. - PubMed
-
- Doney ASF, Dannfald J, Kimber CH, et al. The FTO Gene Is Associated With an Atherogenic Lipid Profile and Myocardial Infarction in Patients With Type 2 Diabetes: A Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) Study. Circ Cardiovasc Genet. 2009;2:255–259. - PMC - PubMed
-
- Lappalainen T, Kolehmainen M, Schwab US, et al. Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism - The Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis. 2010 Apr 16; [Epub ahead of print] - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
